The Mounjaro prescribing information starts at 2.5 mg once weekly for 4 weeks, then 5 mg, with 2.5-mg step-ups (7.5 10 12.5 15 mg) based on response and tolerability (FDA label)
Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes
The medication exerts its therapeutic effects through multiple mechanisms
When combined with healthy eating habits, regular physical activity, and medical guidance, it may help support steady and meaningful weight loss
Generally, the safety profile improves through proper dose titration, beginning at lower doses and gradually increasing based on response and tolerability
While these pharmacies meet regulatory standards, the compounded version of semaglutide itself is not FDA-approved